Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$1.01 - $1.36 $7,189 - $9,680
-7,118 Reduced 92.39%
586 $1,000
Q1 2024

May 07, 2024

BUY
$0.92 - $1.44 $505 - $790
549 Added 7.67%
7,704 $10,000
Q4 2023

Feb 01, 2024

SELL
$0.64 - $6.49 $12,728 - $129,073
-19,888 Reduced 73.54%
7,155 $8,000
Q3 2023

Nov 07, 2023

BUY
$6.56 - $10.95 $1,521 - $2,540
232 Added 0.87%
27,043 $185,000
Q2 2023

Aug 07, 2023

SELL
$7.89 - $10.64 $370 - $500
-47 Reduced 0.17%
26,811 $278,000
Q1 2023

May 02, 2023

SELL
$7.07 - $17.95 $140,558 - $356,863
-19,881 Reduced 42.54%
26,858 $217,000
Q4 2022

Jan 30, 2023

SELL
$14.33 - $18.37 $988 - $1,267
-69 Reduced 0.15%
46,739 $736,000
Q3 2022

Nov 08, 2022

BUY
$13.07 - $18.22 $103,945 - $144,903
7,953 Added 20.47%
46,808 $737,000
Q2 2022

Aug 04, 2022

SELL
$10.16 - $17.08 $1,016 - $1,707
-100 Reduced 0.26%
38,855 $542,000
Q1 2022

May 05, 2022

BUY
$9.74 - $17.92 $74,296 - $136,693
7,628 Added 24.35%
38,955 $672,000
Q4 2021

Feb 02, 2022

SELL
$12.27 - $18.49 $245 - $369
-20 Reduced 0.06%
31,327 $455,000
Q3 2021

Nov 02, 2021

SELL
$13.38 - $18.8 $78,313 - $110,036
-5,853 Reduced 15.73%
31,347 $564,000
Q2 2021

Aug 02, 2021

BUY
$17.08 - $29.6 $635,375 - $1.1 Million
37,200 New
37,200 $653,000
Q2 2020

Aug 07, 2020

SELL
$1.04 - $1.73 $30,834 - $51,292
-29,649 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$16.46 - $20.33 $97,114 - $119,946
5,900 Added 24.84%
29,649 $592,000
Q4 2017

Feb 13, 2018

BUY
$21.47 - $27.8 $47,234 - $61,160
2,200 Added 10.21%
23,749 $586,000
Q3 2017

Nov 06, 2017

SELL
$23.02 - $28.8 $48,618 - $60,825
-2,112 Reduced 8.93%
21,549 $556,000
Q2 2017

Aug 11, 2017

BUY
N/A
23,661
23,661 $642,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.